Seoul Pharma Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	753.64	1,699	3,517	855.09	-9,689
Depreciation & Amortization	2,662	2,490	1,928	2,613	2,528
Loss (Gain) From Sale of Assets	1.78	0.05	8.26	0.02	0.01
Asset Writedown & Restructuring Costs	-	-	-	2,177	198.8
Loss (Gain) From Sale of Investments	-	-67.49	-63.71	-	-
Provision & Write-off of Bad Debts	24.64	-14.53	-6.14	-9.64	24.12
Other Operating Activities	944.03	1,549	2,270	-207.94	4,898
Change in Accounts Receivable	631.55	-4,071	-111.42	-381.62	-1,261
Change in Inventory	523.9	-1,623	-1,920	-2,769	270.5
Change in Accounts Payable	-469.53	-410.48	-164.12	1,020	1,173
Change in Other Net Operating Assets	-3,186	-2,559	-193.42	-3,375	181.78
Operating Cash Flow	1,886	-3,008	5,265	-78.21	-1,675
Capital Expenditures	-861.26	-2,229	-1,893	-1,233	-1,157
Sale (Purchase) of Intangibles	-32.46	-0.7	-1.52	-66.23	-10.71
Investment in Securities	-	3,146	-4,023	-	3.18
Other Investing Activities	50.75	540.74	55	-33	1
Investing Cash Flow	-842.97	1,457	-5,862	-1,332	-1,099
Short-Term Debt Issued	2,000	3,000	-	4,000	4,000
Long-Term Debt Issued	-	10,000	-	-	10,000
Total Debt Issued	2,000	13,000	-	4,000	14,000
Short-Term Debt Repaid	-	-	-4,000	-4,000	-2,000
Long-Term Debt Repaid	-672.39	-10,620	-465.7	-474.25	-10,465
Total Debt Repaid	-672.39	-10,620	-4,466	-4,474	-12,465
Net Debt Issued (Repaid)	1,328	2,380	-4,466	-474.25	1,535
Other Financing Activities	-0	-0	-	-8.94	-0
Financing Cash Flow	1,328	2,380	-4,466	-483.19	1,535
Foreign Exchange Rate Adjustments	38.05	138.15	-91.7	-198.35	1.74
Net Cash Flow	2,408	966.43	-5,155	-2,092	-1,237
Free Cash Flow	1,025	-5,237	3,372	-1,311	-2,831
Free Cash Flow Margin	1.97%	-9.78%	6.43%	-2.62%	-7.00%
Free Cash Flow Per Share	-	-449.20	289.20	-146.00	-332.16
Cash Interest Paid	570.07	427.49	442.51	491.88	457.9
Cash Income Tax Paid	188.68	11.53	4.36	31.28	165.54
Levered Free Cash Flow	-5.64	-7,405	-524.76	-2,459	1,277
Unlevered Free Cash Flow	355.16	-7,129	-248.19	-1,757	1,984
Change in Working Capital	-2,500	-8,663	-2,389	-5,506	364.94

Source: S&P Global Market Intelligence. Standard template. Financial Sources.